CellOxess Competitors and Similar CompaniesClear all

Inflazome's competitors and similar companies include SiteOne Therapeutics.
Inflazome
Inflazome
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
SiteOne Therapeutics
SiteOne Therapeutics
SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
Founding Date
Founding Date
2016
Founding Date
2014
Type
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Dublin 2, IE HQ
Brisbane City, AU
Cambridge, GB
Locations
San Francisco, US HQ
Bozeman, US
Employees
Employees
156% decrease
Employees
2216% increase

Funding

Total funding raised
Total funding raised
$ 17m
Total funding raised
$ 17.8m
For sources of this data, please see the company profile

View Company Profiles

SiteOne Therapeutics
HQ
San Francisco, US
Employees
22↑ 16% increase

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.

View company